seminar on antidepressants
DESCRIPTION
TRANSCRIPT
![Page 1: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/1.jpg)
ANTIDEPRESSANTS
Martha I. Dávila-García, Ph.D.
Howard University College of Medicine
Spring 2002
![Page 2: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/2.jpg)
Classification of Major Affective Disorders
E pisoda lD epress ion
S easona lA ffec tiveD isorder
A typica lD epress ion
M a jor/E ndogenousD epress ion
M ania Bipola rdepress ion
M a jor A ffec tive D isorders
![Page 3: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/3.jpg)
Episodal (reactive) Depression
Adverse life events.Physical illness.Hormonal steroids.Drugs.Other psychiatric disorders.
![Page 4: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/4.jpg)
Reactive (episodal) Depression
More than 60% of all depressions.Core depressive syndrome: feelings
of misery, apathy, inadequacy, pessimism, anxiety, tension, guilt.
Bodily complaintsMay respond spontaneously or to a
variety of administrations.
![Page 5: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/5.jpg)
Major Endogenous Depression
• Recurrent, Cyclic, Seasonal.
• Degree of depression is not adequate for precipitating event.
• Automaton (unresponsive).
![Page 6: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/6.jpg)
Major Endogenous Depression
Core Symptoms: • Feeling of misery, apathy and pessimism.• Withdrawn.• Low self –esteem, feelings of guilt, inadequacy and
ugliness.• Loss of interest in pleasurable activities.• Indecisiveness, loss of motivation.• Retardation of thought and action. Sleep
disturbance and significant weight change (without dieting or changes in appetite).
• Psychomotor agitation or retardation.
![Page 7: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/7.jpg)
Major Endogenous Depression
Core Symptoms (con’t): • In severe cases, it is accompanied by
hallucinations and delusions. • Recurrent suicidal ideation, a suicide attempt or a
specific suicide plan.
![Page 8: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/8.jpg)
Mania
• Mania alone is rare (10%) and most frequently cycles with Major/endogenous depression (Manic-Depressive Disease, Bipolar Disorder).
![Page 9: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/9.jpg)
Mania
Core Symptoms:• It is characterized by an elevated “high” mood.• Talkative, go on-and-on about the things they will
do. • Increased self-esteem.• Auditory hallucinations.• Decrease need to sleep.• Lack judgement, indiscrete.• SuperME
![Page 10: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/10.jpg)
III. Biological Correlates of Depression
1. Hypersecretion of cortisol.
2. Escape from dexamethasone suppression.
3. Blunted TSH response to TRH.
4. Blunted GH response to hypoglycemia.
5. Altered 24hr rhythm of prolactin secretion.
6. Decreased 5-HT metabolites in plasma.
7. Decreased REM latency.
![Page 11: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/11.jpg)
IV. Biological Basis for Depression
1. Has a genetic component.
2. Depression can be drug-induced.
3. Depression can be drug-repressed.
4. Depression can be treated with drugs.
5. Depression can be treated with
Electroconvulsive Therapy (ECT).
![Page 12: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/12.jpg)
• The precise cause of affective disorders remains elusive.
• Evidence implicates alterations in the firing patterns of a subset of biogenic amines in the CNS, Norepinephrine (NE) and Serotonin (5-HT).
Activity of NE and 5 -HT systems?.
V. Biogenic Theory of Depression
![Page 13: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/13.jpg)
VI. NE System
Almost all NE pathways in the brain originate from the cell bodies of neuronal cells in the locus coereleus in the midbrain, which send their axons diffusely to the cortex, cerebellum and limbic areas (hippocampus, amygdala, hypothalamus, thalamus).
• Mood: -- higher functions performed by the cortex.
• Cognitive function: -- function of cortex.• Drive and motivation: -- function of brainstem• Memory and emotion: -- function of the
hippocampus and amygdala.• Endocrine response: -- function of hypothalamus.
and receptors.
![Page 14: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/14.jpg)
VII. Serotonin System
As with the NE system, serotonin neurons located in the pons and midbrain (in groups known as raphe nuclei) send their projections diffusely to the cortex, hippocampus, amygdala, hypothalamus, thalamus, etc. --same areas implicated in depression. This system is also involve in:
• Anxiety.• Sleep.• Sexual behavior.• Rhythms (Suprachiasmatic nucleus).• Temperature regulation.• CSF production.
![Page 15: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/15.jpg)
Antidepressants
• TCAs
MAOIs
SS
RIs
TCAs
TCAs
TCAs
TC
As
SSRIs
SSRIs
SS
RIs
SSRIs
MAOIs
MAOIsMAOIs
MAOIs
MAOIs
MAOIs
Venflaxine
Ven
flaxine
Ven
flaxine
MAOIs
MAOIs
maprotiline
Amoxepine
doxepin
isocarboxazide
Nortriptyline
![Page 16: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/16.jpg)
Antidepressants
1. Tricyclic anti-depressants (TCAs).
Imipramine, desipramine, nortriptyline,
protryptyline, amytriptiline, doxepin.
2. Monoamine oxidase inhibitors (MAOIs).
Isocarboxacid, phenelzine, tranylcypromine.
3. Selective serotonin reuptake inhibitors (SSRIs)
Fluoxetine, sertraline, paroxetine, trazodone.
4. Atypical anti-depressants (Others)
New TCAs, amoxapine, bupropion,
alprazolam, maprotiline, nomifensine, mianserin.
![Page 17: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/17.jpg)
Mechanism of Action
1. Inhibition of NE and 5-HT reuptake. (TCAs, SSRIs, Newer TCAs).
2. Inhibition of MAO enzymes.(MAOIs).
3. 5-HT2A and 5-HT2C antagonists.(Nefazodone, trazodone, mirtazapine)
4. Alteration of NE output . (Bupropion)
5. Stimulation of 5-HT1A receptors.(
6. 2–AR antagonists.(mirtazapine)
![Page 18: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/18.jpg)
Tricyclic Antidepressants (TCAs)
•amytriptiline
• imipramine
•desipramine
•nortriptyline
•protryptyline
•doxepin.
![Page 19: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/19.jpg)
Tricyclic Antidepressants (TCAs)
• Characteristic three ring nucleus.• Most are incompletely absorbed, all are
metabolized in liver => High first pass effect:1) Transformation of the tricyclic nucleus
=> hydroxylation => conjugation => glucoronides.
2) Alteration of aliphatic side chain => demethylation of the nitrogen => active metabolites.
• High protein binding, high lipid solubility.
![Page 20: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/20.jpg)
Tricyclic Antidepressants (TCAs)
/ CH3 / H
N N
\ CH3 \ CH3
tertiary amine secondary amine
3o => 2o
![Page 21: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/21.jpg)
Tricyclic Antidepressants (TCAs)
3°Amines: Imipramine, Amitriptyline
2°Amines: Desipramine, Nortriptyline
Selectivity 2o Amines -- NE > 5-HT
3o Amines -- 5-HT > NE
![Page 22: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/22.jpg)
Tricyclic Antidepressants (TCAs)Mechanism of Action:
- Inhibition of NT reuptake.
- Immediate action = > NE and 5-HT in synapse.
- After chronic treatment (2 - 4 weeks) = >
NE-R and 5-HT2R.
NE release and turnover.
NE-stimulated cAMP in brain.
Sensitization of 5-HT receptors.
* Adaptive Responses *
- Takes up to 4 weeks for all TCA antidepressants to have an effect.
![Page 23: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/23.jpg)
Tricyclic Antidepressants (TCAs)Side Effects:
• Atropine-like side effects: dry mouth, paradoxical excessive perspiration, constipation, blurred vision, mydriasis, metallic taste, urine retention => muscarinic blockade.
• Orthostatic hypotension => 1-AR and possibly 2-AR blockade.
• Drowsiness, sedation and weight gain => Histamine-Receptor blockade.
![Page 24: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/24.jpg)
Tricyclic Antidepressants (TCAs)Side Effects (con’t):
• Most serious side effect is cardiac toxicity => Palpitations, tachycardia, dizziness => excessive CNS stimulation => NE in Heart.
• Sexual dysfunction, including loss of libido, impaired erection and ejaculation and anorgasmia
. COMPLIANCE
![Page 25: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/25.jpg)
Tricyclic Antidepressants (TCAs)Other effects (con’t):• Metabolism is affected by: Smoking, Barbs,
estrogens, neuroleptics and anticonvulsants.• Can lower seizure threshold.• All TCAs can cause: vagal block, postural
hypotension, arrythmias, sinus tachycardia.• All potentiate CNS depressants (BZDs, Barbs,
ETOH) => coma and death.• TCA administration in bipolar disorder may
precipitate acute mania or rapid cycling.• Fatal in overdose (a 2 wk supply can kill anyone).
![Page 26: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/26.jpg)
X. MAO INHIBITORS
•Isocarboxacid
•Phenelzine
•Tranylcypromine.
![Page 27: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/27.jpg)
X. MAO INHIBITORS
• Developed for the treatment of tuberculosis (iproniazid derivatives) - 1951.
• These drugs are not widely used today, although a small number of patients appear to do better in MAOIs than TCAs or the newer drugs.
• Are readily absorbed from GI tract and widely distributed throughout the body.
• May have active metabolites, inactivated by acetylation.
• Effects persist even after these drugs are no longer detectable in plasma (1-3 weeks).
![Page 28: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/28.jpg)
X. MAO INHIBITORS
Mechanism of action:Inhibit MAO enzymes (non-selective):
1) Irreversible MAO inhibitors
Phenelzine and isocarboxazid => hydrazides.
2) Reversible MAO Inhibitors.
Tranylcypromine => non-hydrazide,
prolonged blockade, but reversible within 4hr.
Decrease metabolism of most biogenic amines (NE, 5HT, DA, tyramine, octopamine).
![Page 29: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/29.jpg)
X. MAO INHIBITORS
Mechanism of action (con’t):
Acute administration causes: NE and 5-HT in synaptic terminals in brain but
NE in PNS. NE synthesis.
– Acute euphoria
– Suppressed REM sleep.
Chronic administration causes: NE-stimulated cAMP in brain.
– Down regulation of receptors.
– Down regulation of 5-HT2 receptors.
![Page 30: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/30.jpg)
X. MAO INHIBITORS
MAO-A NE, 5-HT, Tyramine
MAO-B DA
Selective MAOIs:Inhibitors MAO-A
Moclobemide, Clorgyline Inhibitors of MAO-B.
Deprenyl, Selegiline
![Page 31: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/31.jpg)
X. MAO INHIBITORS
Wine-and-Cheese Reaction- Fatal interaction with tyramine-containing
foods (fermented foods in particular, such as wine and cheese).
- MAO-A => Tyramine in the body =>NE in circulation => induces hypertensive crisis => can lead to intracranial bleeding and other organ damage.
![Page 32: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/32.jpg)
X. MAO INHIBITORS
Negative drug interactions with:
Any drug metabolized by MAOs* including SSRIs, TCAs and meperidine, alcohol, CNS depressants, sympathomimetics, phenylephrine (O/C nasal decongestants), ampetamines, and other indirect-acting adrenergic drugs.
* Interaction with drugs metabolized by MAOs (e.g. Meperidine (opioid analgesics) => hyperpyrexia or “hyperexcitation syndrome” involving high fever, delirium and hypertension).
![Page 33: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/33.jpg)
X. MAO INHIBITORS
Other side effects:
• Hypotension
• Hepatotoxicity.
• Sedation.
![Page 34: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/34.jpg)
XI. SSRIs
•Fluoxetine
•Sertraline
•Paroxetine
•Fluvoxamine(Labeled for obsessive-compulsive disorder)
![Page 35: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/35.jpg)
XI. SSRIs
• Most widely prescribed drugs for depression.
• They have few side effects and seem to be rather safe. More rational prescribing and better patient compliance.
• Adverse effects include: nausea, decreased libido, decrease sexual function.
• Low threat for overdose. Suicide may be considered in severe depression.
![Page 36: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/36.jpg)
XI. SSRIs
Mechanism of action:• Specific serotonin uptake inhibitors increase
5-HT by inhibiting reuptake.
Current theory holds that:• Enhanced stimulation or responsiveness of
postsynaptic 5-HT1A receptors is particularly important in the action of antidepressants.
![Page 37: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/37.jpg)
XI. SSRIs
Fluoxetine is the prototype.• Approximately 70% of depressed patients will
respond to an SSRI therapy at the end of 6 weeks (4 to 6 weeks before effects are evident to patient).
• T1/2 of 16 – 24 hrs. except for fluoxetine’s metabolite norfluoxetine (T1/2 = 8 days).
• Fluoxetine and paroxetine inhibit liver enzymes, particularly P450-2D6.
• Paroxetine and Sertraline have PK parameters similar to TCAs.
![Page 38: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/38.jpg)
XI. SSRIs
Drug-drug interactions:
dangerous with other antidepressant drugs, MAOIs in particular.
”Serotonin Syndrome”:– hyperthermia, muscle rigidity, myoclonus, rapid
changes in mental status and vital signs.
Thus it is important to wait up to 6 weeks after medication is stopped, before starting with another drug.
![Page 39: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/39.jpg)
XII. Heterocyclics2nd Generation heterocyclics
• amoxapine• maprotiline• trazodone• bupropion
Third Generation heterocyclics• mirtazapine• venlafaxine• nefazodone
![Page 40: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/40.jpg)
XII. Heterocyclics• The second and third generation antidepressants
are by no means a homogeneous group.• As with the TCA's , they all have variable
bioavailability.• High protein binding.• Some have active metabolites.• Trazodone and Venlafaxine have the shortest
plasma half-lives, which mandates divided doses during the day.
• Nefazodone and fluvoxamine cause inhibition of CYP3A4.
![Page 41: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/41.jpg)
XII. Heterocyclics
Mechanism of Action:1) NT reuptake inhibition.
maprotiline.2) 5-HT receptor antagonism (for 5-HT2A
or 2C receptors).nefazodone, mirtazapine, and trazodone
3) Alteration of NE Output.bupropion, amoxapine, and
trazodone.
![Page 42: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/42.jpg)
XII. Heterocyclics
Amoxapine. Metabolite of Loxapine (an anti-psychotic) -- retains some antipsychotic activity and DA receptor antagonism => parkinson's-like symptoms. May be useful if psychosis is present. NE output.
Maprotiline. A tetracyclic drug, resembles desipramine with less sedative and antimuscarinic side effects. Evokes seizures at high doses. Blocks NT reuptake.
![Page 43: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/43.jpg)
XII. Heterocyclics
Trazodone. Antagonist of 5-HT2A or 2C receptors. Unpredictable efficacy. Highly sedative (hypnotic), but minimal antimuscarinic action.
Bupropion. Resembles amphetamine. Blocks DA reuptake (not important in depression). Causes CNS stimulation. Inhibits appetite. Aggravates psychosis. NE output.
![Page 44: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/44.jpg)
XII. Heterocyclics Third Generation
Mirtazapine. A derivative of mianserin. Antagonist of 5-HT2A or 5-HT2C receptors. Also antagonizes 2-adrenergic receptors, thus increasing NE and 5-HT release. Very sedating.
Venlafaxine. Short plasma half-live, thus needs to be given in divided doses. Potent inhibitor of 5-HT uptake and weaker at NE reuptake (at low concentrations it acts like an SSRI).
Nefazodone. Antagonist of 5-HT2A or 5-HT2C receptors. Moderately sedating. Potent inhibitor of CYP3A4, so cannot be given with cisapride
![Page 45: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/45.jpg)
XII. Atypical/Heterocyclic 2nd Generation heterocyclics
• Amoxapine• Maprotiline• Trazodone• Bupropion
Third Generation heterocyclics• Mirtazapine• Venlafaxine• Nefazodone
Similar to TCAs
5-HT antagonists
2-AR antagonist
SSRI-like
NE output
![Page 46: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/46.jpg)
Noradrenergic Control of Serotonergic Release
NE5-HT
NE
2-AR
1-AR
1 2 3
Mianserin
5-HT1
5-HT2
5-HT3
Receptors
![Page 47: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/47.jpg)
XIV. Alternative Therapies
No way of a priori knowing which therapy will be best for a patient.
• Light Therapy
• Psychological Treatment
• ECT
• St. John’s Wort
![Page 48: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/48.jpg)
![Page 49: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/49.jpg)
![Page 50: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/50.jpg)
![Page 51: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/51.jpg)
XVI. Anti-Manic DrugsLithium (Li+) remains the drug of choice for the
treatment and prophylaxis of mania.• Acute manic episodes are managed with lithium
salts (carbonate or citrate) alone, or in combination with:
1) Antipsychotics (carbamazepine, similar in structure to TCAs but not effective in depression).
2) Valproic acid
3) Calcium-channel blockers (nifendipine, diltiazem, verapamil).
![Page 52: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/52.jpg)
XVI. Anti-Manic Drugs
Li+
• Small monovalent cation (between H+ and Na+).
• Distributed in total body water, similar to sodium.
• May partially inhibit Na+-K+ ATPase.• Inhibits ADH => diuresis.• May decrease thyroid function.• Teratogenic (tricuspid valve malformation).• Excreted by kidney.
![Page 53: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/53.jpg)
XVI. Anti-Manic Drugs
Li+
• Not to be taken with thiazide diuretics (e.g. chlorthiazide).
• Lithium clearance is reduced by 25%.
• All neuroleptics (with the exception of clozapine), produce more severe extrapyramidal syndromes when combined with lithium.
![Page 54: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/54.jpg)
XVI. Anti-Manic Drugs
Li+
• Helps alleviate the depressive phase of bipolar illness.
• Useful in refractory depression when added to SSRIs or TCAs, but not a good antidepressant alone.
![Page 55: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/55.jpg)
XVI. Anti-Manic Drugs
Li+
Mechanism of action:• Does not alter receptor numbers but alters the
coupling of the receptors with their second messengers by reducing coupling of G-proteins.
• Regulation of -AR and DAR.• Can reduce release of NTs (5-HT) and affinity of
binding to receptor.
![Page 56: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/56.jpg)
XVI. Anti-Manic Drugs
Li+
Mechanism of action (Con’t):Inhibits breakdown of IP2 to IP1 (during PIP
hydrolysis) => depletion of DAG and IP3 and [Ca2+] in response to receptor activation (i.e. from 5-HT2R, 1-AR, muscarinic receptors and others).
• Alterations in adenylate cyclase and phospholipase C.
![Page 57: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/57.jpg)
XVI. Anti-Manic Drugs
PIP
PIP2
G IP3
IP2
IP1
InositolPI
X Li+
PLC
DAG
Ca 2+
![Page 58: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/58.jpg)
XVI. Anti-Manic Drugs
Valproic AcidA well known antiepileptic has been found to
have antimanic effects. Shows efficacy equivalent as that of lithium during the early weeks of treatment and is being evaluated for maintenance treatment. Titrated well, the sedation can be controlled. Nausea being the only limiting factor in some patients.
May be used as first line treatment for mania, although it may not be as effective in maintenance treatment as lithium for some patients.
Mechanism of action: ???
![Page 59: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/59.jpg)
XVI. Anti-Manic Drugs
CarbamazepineEffective as an antimania medication
Mechanism of action (Con’t):
May be due to decrease overexcitability of neurons (anticonvulsive effect).
![Page 60: Seminar On Antidepressants](https://reader035.vdocuments.us/reader035/viewer/2022081716/54660421af795969458b4d42/html5/thumbnails/60.jpg)
XVI. Anti-Manic Drugs
Ca2+ Channel blockersNifedeipine
Verapamil
Mechanism of action (Con’t):
NT Release?